Diagnostic, prognostic and therapeutic aspects of apelin in cardiovascular diseases
Authors:
- Amina M. AlievaAAAmina M. Alieva
- Natalia V. TeplovaNTNatalia V. Teplova
- Elena V. ReznikERElena V. Reznik
- Irina E. BaykovaIBIrina E. Baykova
- Nyurzhanna Kh. KhadzhievaNKNyurzhanna Kh. Khadzhieva
- Bela Z. BalagovaBBBela Z. Balagova
- Alik M. RakhaevARAlik M. Rakhaev
- Dzhannet A. ElmurzaevaDEDzhannet A. Elmurzaeva
- Madina Ya. ShavaevaMSMadina Ya. Shavaeva
- Irina A. KotikovaIKIrina A. Kotikova
- Igor G. NikitinINIgor G. Nikitin
- 14 March 2024
- journal article
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 30 (1) , 48-66
Abstract
Biological markers have been thoroughly incorporated into clinical practice as a convenient and simple method for diagnosing and monitoring the condition of patients. The analysis of biomarkers has found its niche in oncology; however, their application in cardiovascular diseases is still in its infancy. Studies on apelin indicate the potential diagnostic and prognostic significance of the assessment of this marker in patients with cardiovascular diseases. The beneficial effect of apelin on the heart and blood vessels allows us to consider this marker as a therapeutic target. The combination of apelin with other biological markers, particularly brain natriuretic peptide and its precursor, may increase the predictive value of apelin.Keywords
This publication has 97 references indexed in Scilit:
- Structure–function relationship and physiological role of apelin and its G protein coupled receptorBiophysical Reviews, 2023
- Apelin-13 Improves Cognitive Impairment and Repairs Hippocampal Neuronal Damage by Activating PGC-1α/PPARγ SignalingNeurochemical Research, 2022
- A Novel Peptide Elabela is Associated with Hypertension-Related Subclinical AtherosclerosisHigh Blood Pressure & Cardiovascular Prevention, 2022
- Apelin/APJ system: an emerging therapeutic target for neurological diseasesMolecular Biology Reports, 2022
- Zinc finger E‐box binding homeobox 1 and atherosclerosis: New insights and therapeutic potentialJournal of Cellular Physiology, 2020
- ELABELA (ELA) Peptide Exerts Cardioprotection Against Myocardial Infarction by Targeting Oxidative Stress and the Improvement of Heart FunctionInternational Journal of Peptide Research and Therapeutics, 2018
- Biological functions of Elabela, a novel endogenous ligand of APJ receptorJournal of Cellular Physiology, 2018
- Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heartBasic Research in Cardiology, 2015
- Relationship between plasma apelin level and coronary collateral circulationAtherosclerosis, 2014
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998